![glucagon and glp 1 Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://upload.wikimedia.org/wikipedia/commons/6/64/Incretins_and_DPP_4_inhibitors.svg)
glucagon and glp 1 Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]
Description
One notable example is the Micro-Infusion Hair Growth Treatment by Grwoots
![glucagon and glp 1 Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
The most commonly prescribed medications in this category include semaglutide 2.4 mg (Wegovy) and tirzepatide (Zepbound), which are FDA-approved specifically for chronic weight management
![glucagon and glp 1 Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig2_HTML.png)
Another GLP-1/GIP/glucagon receptor triagonist known as retatrutide (previously LY3437943) was developed by Eli Lilly in 2022 leading to weight loss, reduced fat mass, decreased blood glucose and insulin levels in obese mice, which was attributed to increased energy expenditure and lipid oxidation [62]
![glucagon and glp 1 Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://b1167102.smushcdn.com/1167102/wp-content/blogImages/10222025/glp105.jpg?lossy=2&strip=1&webp=1)
282285, Jan
![glucagon and glp 1 Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://selfhacked.com/app/uploads/2016/05/nrendo.2012.140-f1.jpg)
Drug Type/Class 17.12.3
![glucagon and glp 1 Glucagon-like peptide-1 glp-1_analogs [TUSOM | Pharmwiki]](https://www.mdpi.com/ijms/ijms-20-03445/article_deploy/html/images/ijms-20-03445-g001.png)
